I alle undersøgelserne var hovedmålestokken for effekt enten den samlede overlevelsestid eller den progressionsfrie overlevelsestid (den tid, det tager, inden sygdommen forværres, eller til patienten dør).
In all of the studies, the main measure of effectiveness was either overall survival time or progression- free survival time (the time taken for the disease to get worse or for the patient to die).